Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
Conduit Pharmaceuticals Inc. (CDT) had Normalized Income after Taxes of $-17.80M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-17.80M |
|
-- |
|
-- |
|
$15.42M |
|
$-15.42M |
|
$-2.38M |
|
$-17.80M |
|
$-17.80M |
|
$-17.80M |
|
$-17.80M |
|
$-17.80M |
|
|
Normalized Income after Taxes |
$-17.80M |
$-15.42M |
|
$-12.37M |
|
0.87M |
|
0.87M |
|
$-20.53 |
|
$-20.53 |
|
| Balance Sheet Financials | |
$2.71M |
|
$0.04M |
|
$1.48M |
|
$4.19M |
|
$10.74M |
|
-- |
|
$0.24M |
|
$10.99M |
|
$-6.79M |
|
$-6.79M |
|
$-6.79M |
|
1.38M |
|
| Cash Flow Statement Financials | |
$-9.68M |
|
$-0.04M |
|
$6.07M |
|
$4.23M |
|
$0.55M |
|
$-3.67M |
|
$1.63M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.25 |
|
-- |
|
-- |
|
-- |
|
-1.06 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-9.73M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
262.06% |
|
262.06% |
|
-424.56% |
|
262.06% |
|
$-4.91 |
|
$-11.22 |
|
$-11.17 |
|